Albuminuria in Transthyretin Cardiac Amyloidosis: Prevalence, Progression and Prognostic Importance
European Journal of Heart Failure · 2024
DOI: 10.1002/ejhf.3094 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Heart Failure, 2024. Verfasst von Adam Ioannou und 18 weiteren Autor:innen. Beteiligte Einrichtung: National Amyloidosis Centre, University College London, Royal Free Campus, London, UK. Hauptthemen laut MEDLINE: Heart Failure, Amyloidosis, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.
Abstract (Originalsprache)
Aims
Transthyretin cardiac amyloidosis (ATTR-CA) is an infiltrative cardiomyopathy that commonly presents with concomitant chronic kidney disease. Albuminuria is common in heart failure and associated with worse outcomes, but its prevalence and relationship to outcome in ATTR-CA remains unclear. Methods and results A total of 1181 patients with ATTR-CA were studied (mean age 78.1 ± 7.9 years; 1022 [86.5%] male; median estimated glomerular filtration rate 59 ml/min/1.73m2 [interquartile range: 47–74]). Albuminuria was present in 563 (47.7%) patients (499 [88.6%] with microalbuminuria and 64 [11.4%] with macroalbuminuria). Patients with albuminuria had a more severe cardiac phenotype evidenced by higher serum cardiac biomarkers (median N-terminal pro-B-type natriuretic peptide [NT-proBNP]: 4027 ng/L [2173–6889] vs. 1851 ng/L [997–3209], p < 0.001; median troponin T: 69 ng/L [46–101] vs. 48 ng/L [34–68], p < 0.001) and worse echocardiographic indices of systolic (longitudinal strain: −10.0 ± 3.6% vs. −11.6 ± 3.8%, p < 0.001) and diastolic function (E/e′: 17.5 ± 6.4 vs. 16.4 ± 6.7, p < 0.001) than those with a normal urinary albumin to creatinine ratio (UACR). Microalbuminuria and macroalbuminuria were independently associated with mortality in the overall population (hazard ratio [HR] 1.47, 95% confidence interval [CI] 1.13–1.92, p = 0.005 and HR 1.87, 95% CI 1.15–3.05, p = 0.012, respectively). In a subgroup of patients (n = 349) without concomitant hypertension, diabetes mellitus or chronic kidney disease, albuminuria was also associated with mortality (HR 2.98, 95% CI 1.72–5.17, p < 0.001). At 12 months, 330 patients had a repeat UACR measurement; those in whom UACR increased by 30% or more (n = 148, 44.8%) had an increased risk of mortality (HR 1.84, 95% CI 1.06–3.19, p = 0.030).
Conclusions
Albuminuria is common in patients with ATTR-CA, and more prevalent in those with a more severe cardiac phenotype. Albuminuria at diagnosis and a significant increase in UACR during follow-up are associated with mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Amyloidosis Centre, University College London, Royal Free Campus, London, UK.
- Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
- Cardiology University Department, IRCCS Policlinico San Donato, Milan, Italy.
- University College London, London, UK.
- Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Adam Ioannou
Förderung
- British Heart Foundation
Zitieren
APA
Ioannou, A., Rauf, M. U., Patel, R. K., Razvi, Y., Porcari, A., Martinez-Naharro, A., Venneri, L., Bandera, F., Virsinskaite, R., Kotecha, T., Knight, D., Petrie, A., Whelan, C., Wechalekar, A., Lachmann, H., Hawkins, P. N., Solomon, S. D., Gillmore, J. D., & Fontana, M. (2024). Albuminuria in Transthyretin Cardiac Amyloidosis: Prevalence, Progression and Prognostic Importance. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3094
Vancouver
Ioannou A, Rauf MU, Patel RK, Razvi Y, Porcari A, Martinez-Naharro A, et al. Albuminuria in Transthyretin Cardiac Amyloidosis: Prevalence, Progression and Prognostic Importance. European Journal of Heart Failure. 2024. doi:10.1002/ejhf.3094
BibTeX
@article{Ioannou2024,
author = {Ioannou, Adam and Rauf, Muhammad U and Patel, Rishi K and Razvi, Yousuf and Porcari, Aldostefano and Martinez-Naharro, Ana and Venneri, Lucia and Bandera, Francesco and Virsinskaite, Ruta and Kotecha, Tushar and Knight, Dan and Petrie, Aviva and Whelan, Carol and Wechalekar, Ashutosh and Lachmann, Helen and Hawkins, Philip N and Solomon, Scott D and Gillmore, Julian D and Fontana, Marianna},
title = {Albuminuria in Transthyretin Cardiac Amyloidosis: Prevalence, Progression and Prognostic Importance},
journal = {European Journal of Heart Failure},
year = {2024},
doi = {10.1002/ejhf.3094}
}
EUVIMED